AAAAAA

   
Results: 1-10 |
Results: 10

Authors: FEDERICO M CLO V BURGIATELLI M CAROTENUTO M GOBBI PG VALLISA D LOMBARDO M AVANZINI P DIRENZO N DINI D BALDINI L SILINGARDI V
Citation: M. Federico et al., EFFICACY OF 2 DIFFERENT PROMACE-CYTABOM DERIVED REGIMENS IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A MULTICENTER TRIALCONDUCTED BY GISL, Haematologica, 83(9), 1998, pp. 800-811

Authors: GOBBI PG PIERESCA C GHIRARDELLI ML DIRENZO N FEDERICO M MERIL F IANNITTO E PITINI V GRIGNANI G DONELLI A CAROTENUTO M SILINGARDI V
Citation: Pg. Gobbi et al., LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE, Blood, 91(8), 1998, pp. 2704-2712

Authors: NADALI G TAVECCHIA L ZANOLIN E BONFANTE V VIVIANI S CAMERINI E MUSTO P DIRENZO N CAROTENUTO M CHILOSI M KRAMPERA M PIZZOLO G
Citation: G. Nadali et al., SERUM LEVEL OF THE SOLUBLE FORM OF THE CD30 MOLECULE IDENTIFIES PATIENTS WITH HODGKINS-DISEASE AT HIGH-RISK OF UNFAVORABLE OUTCOME, Blood, 91(8), 1998, pp. 3011-3016

Authors: BRUGIATELLI M FEDERICO M GOBBI P DIRENZO N VALLISA D ANGRILLI F COLOMBI M ASCARI E SILINGARDI V AMADORI S
Citation: M. Brugiatelli et al., COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL), Blood, 90(10), 1997, pp. 840-840

Authors: GOBBI PG PIERESCA C FRASSOLDATI A CAROTENUTO M DIRENZO N LASALA A BERTE R AVANZINI P FEDERICO M SILINGARDI V ASCARI E
Citation: Pg. Gobbi et al., VINBLASTINE, BLEOMYCIN, AND METHOTREXATE CHEMOTHERAPY PLUS EXTENDED-FIELD RADIOTHERAPY IN EARLY, FAVORABLY PRESENTING, CLINICALLY STAGED HODGKINS PATIENTS - THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI EXPERIENCE, Journal of clinical oncology, 14(2), 1996, pp. 527-533

Authors: MOLICA S LEVATO D DIRENZO N LASALA A CAROTENUTO M
Citation: S. Molica et al., AN ALL-ORAL COMBINATION THERAPY IN CHRONIC LYMPHOCYTIC-LEUKEMIA INCLUDING THE ORAL IDARUBICIN, American journal of hematology, 52(3), 1996, pp. 235-236

Authors: GRIGNANI G BRUGIATELLI M GOBBI PG PIERESCA C DIRENZO N IANNITTO E MOLICA S SANTAGATI G GINALDI L CARACCIOLO F SILINGARDI V
Citation: G. Grignani et al., INTERNATIONAL PROGNOSTIC INDEX (IPI) AND AGE-ADJUSTED IPI (AA-IPI) ARE IMPROVED BY TUMOR BURDEN (TD) EVALUATION, Blood, 88(10), 1996, pp. 905-905

Authors: FEDERICO M GOBBI PG MORETTI G AVANZINI P DIRENZO N CAVANNA L ASCARI E SILINGARDI V
Citation: M. Federico et al., EFFECTS OF THYMOSTIMULIN WITH COMBINATION CHEMOTHERAPY IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA, American journal of clinical oncology, 18(1), 1995, pp. 8-14

Authors: MOLICA S DATTILO A MANNELLA A LEVATO D MUSTO P DIRENZO N LASALA A CAROTENUTO M
Citation: S. Molica et al., SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 CORRELATES WITH MARKERS OF DISEASE-ACTIVITY IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 85(8), 1995, pp. 2280-2281

Authors: DIRENZO N
Citation: N. Direnzo, EPODOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL (VOL 78, PG 306, 1993), Haematologica, 78(6), 1993, pp. 425-425
Risultati: 1-10 |